You just read:

New Halaven® (Eribulin) and Lenvatinib Data to be Presented at ESMO 2014 Demonstrates Strength of Eisai Oncology Portfolio

News provided by

Eisai Europe Limited

17 Sep, 2014, 00:01 BST